Drug Information Association Logo

Drug Induced Liver Injury (DILI)

Sep 4 2014 9:00AM - Sep 5 2014 5:00PM | Shanghai Qilu Courtyard Hotel 838 Dongfang Road, Pudong 200012 Shanghai China

« Back to Listing


Drug Induced Liver Injury (DILI) is one of the greatest safety concerns in drug development. This workshop will bring together regulators from CFDA & FDA, academia Key Opinion Leaders and global industrial professionals to share their experiences in relation to the barriers and opportunities in assessing DILI. Key topics will include how to detect clinical DILI signals and perform liver safety assessments, and getting to know China-specific issues in the field, including herbal, antiTB drugs and antibiotics.

Who Should Attend 

  • Clinicians
  • Drug Development Professionals
  • Industrial Pre and Post-marketed PV Professionals
  • Protocol Design Professionals
  • Regulatory Affairs Professionals
  • The HCPs who have interest in DILI

Learning Objectives 

  • Explain DILI observation and best practices
  • Discuss how detect clinical DILI signals and perform liver safety assessment
  • Get to know China specified DILI, by herbal, antiTB drug and antibiotics

Registration Fees 

Other Fees

Member Student
NonMember Student


Charitable Nonprofit/Academia Member
Member Government
Member Standard


Charitable Nonprofit/Academia Nonmember
NonMember Government
NonMember Standard
Register Online
« Back to Listing Back To Top